蘭花是高科技、高資本之產業,如何使蘭花生產上之科技含量提高,來創造產業價值,生物科技之有效應用是重要關鍵。蓋生物科技之發展與應用有改變製造業或使用消耗品之投入產出關係,進而擺脫報酬遞減之傳統法則。蝴蝶蘭產業之生物技術相當先進,其中生物科技之發展經產、官、學、研多年之努力,已有許多關鍵技術與製程獲得專利,未來如何將已申請專利之技術、製程及產品等加以整合,是創造生物科技在蝴蝶蘭產業中價值之重要因素。因此,將生物科技含量頗高之蘭花產業導入科技管理因素,轉化知識成為貨幣價值,是確保生物科技提高蘭花產業附加價值的重要關鍵。 本研究係針對台灣蝴蝶蘭產業中所採用之生物技術,如組織培養、健康管理以及保鮮技術等之導出,進行瞭解與訪查,並針對蝴蝶蘭生產過程中各項生物技術之整合,進而對其做投資評估。研究目的在於瞭解蝴蝶蘭不同生產階段之風險;評估蝴蝶蘭不同生產階段之風險值;建立不同蝴蝶蘭投資評估模式,並比較不同規模別投資差異;擬定蝴蝶蘭產業之投資決策。 根據本文結果,目前台灣蝴蝶蘭產業之投資,尚屬獲利階段。但業者因未考量生產風險下,投資評估有高估現象。然而,蝴蝶蘭投資獲利與規模別大小並無直接關聯,但與所處蝴蝶蘭產業價值鏈階段則有獲利上之明顯差異。
The biotechnology is a key technology for 21st century. The development of bio-tech would change the input-output relation for manufacture and agriculture production due to duplication of biogenes. However, bio-tech per se will not create its own value. Technology management becomes one of critical factors to create technology value in the process of production. This paper tries to evaluate the effective technology management and creation of industry value for phalaenopsis from the aspects of technology management, investment assessment and business management model. The project by using primary data interviewing from orchid farmers evaluate the value of Phalaenopsis industry and core technology in the process production. The NPV approach has been adapted to access the investment behavior.